Both SARS-Cov-2 and nicotine bind to the ACE2 receptor. One hypothesis is that because SARS-Cov-2 has to compete with nicotine for the receptor it ends up being less effective. Another hypothesis is that smokers tend to do better because of nicotine's effect of reducing inflammation.